Randomized, Double blind, Two Arm, Comparative Controlled, Prospective Clinical Trial of Mycobacterium w in Combination with Standard Therapy versus Standard Therapy Alone in Sepsis due to Gram Negative Infection

Trial Profile

Randomized, Double blind, Two Arm, Comparative Controlled, Prospective Clinical Trial of Mycobacterium w in Combination with Standard Therapy versus Standard Therapy Alone in Sepsis due to Gram Negative Infection

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Cadi 05 (Primary)
  • Indications Sepsis; Septic shock
  • Focus Therapeutic Use
  • Sponsors Cadila Pharmaceuticals
  • Most Recent Events

    • 02 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top